Fleming MedLab is a medical robotics startup focusing on stroke rehabilitation. We help stroke survivors to walk again and recover their brains with our wearable robots (exoskeletons).
We designed our medical-grade robots with our patented technology based on neuroscience principles. With our machine-learning algorithm, we help therapists and patients improve their recovery efficacy and predict their prognosis.
We work directly with hospitals, rehabilitation centers, and physiotherapy clinics. By helping patients early, we can maximize recovery outcomes.
Currently, we have 3 US patents and are in the 1st clinical trial phase. We are ready for a soft launch to the market in 2023 Q2.
Our goal is to help 41,000 stroke patients daily to regain mobility, rebuild neural pathways, and get back on life.